Associated Papers
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder - A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape.
Singh A et al.
Journal of Autoimmunity, 2025
Neurological manifestations in patients with VEXAS syndrome.
Bert-Marcaz C et al.
Journal of Neurology, 2025
Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront.
Li XX et al.
Molecular Medicine (cambridge, Mass.), 2024
Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.
Kouranloo K et al.
Rheumatology International, 2024
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome.
Borie R et al.
Chest, 2023
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Georgin-Lavialle S et al.
The British Journal of Dermatology, 2022
Select a paper to view details